ImmunoCap
Device
Phadia AB
Total Payments
$13,001
Transactions
7
Doctors
2
Companies
1
Payment Trends by Year
| Year | Amount | Transactions | Doctors |
|---|---|---|---|
| 2017 | $13,001 | 7 | 2 |
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Travel and Lodging | $7,262 | 2 | 55.9% |
| Honoraria | $4,988 | 2 | 38.4% |
| Unspecified | $616.22 | 2 | 4.7% |
| Food and Beverage | $135.00 | 1 | 1.0% |
Payments by Type
General
$12,385
5 transactions
Research
$616.22
2 transactions
Research Studies & Clinical Trials
About ImmunoCap
ImmunoCap is a device associated with $13,001 in payments to 2 healthcare providers, recorded across 7 transactions in the CMS Open Payments database. The primary manufacturer is Phadia AB.
Payment data is available from 2017 to 2017. In 2017, $13,001 was paid across 7 transactions to 2 doctors.
The most common payment nature for ImmunoCap is "Travel and Lodging" ($7,262, 55.9% of total).
ImmunoCap is associated with 2 research studies, including "Comparison of galactose-alpha-1,3-galactose containing antigens for detection of alpha-gal sIgE in mammalian meat allergic patients." ($600.60).